Vysis CLL FISH Probe Kit

FDA Premarket Approval P150041 S006

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Use of alternative parts for in-process testing

DeviceVysis CLL FISH Probe Kit
Generic NameFluorescence In Situ Hybridization, Chromosome 17p Deletion (tp53)
ApplicantABBOTT MOLECULAR, INC.
Date Received2020-11-16
Decision Date2020-12-11
PMAP150041
SupplementS006
Product CodePNK 
Advisory CommitteePathology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address ABBOTT MOLECULAR, INC. 1300 East Touhy Avenue des Plaines, IL 60018

Supplemental Filings

Supplement NumberDateSupplement Type
P150041Original Filing
S006 2020-11-16 30-day Notice
S005 2019-04-10 30-day Notice
S004 2018-08-10 30-day Notice
S003 2018-06-15 30-day Notice
S002 2018-02-16 30-day Notice
S001 2017-11-08 30-day Notice

NIH GUDID Devices

Device IDPMASupp
00884999042780 P150041 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.